Former Secretaries of the Treasury to Deliver Keynote at the 2012 BIO International Convention

• Contact: Abigail Hirsch
• Phone: 202-962-9235
• Email: ahirsch@bio.org

WASHINGTON, DC – (May 21, 2012) – Former Secretaries of the Treasury will share their thoughts on the state of the global economy during a Keynote Luncheon panel, titled “State of the Global Economy: A Conversation with Former Secretaries of the Treasury Robert E. Rubin and Henry M. Paulson, Jr.,” on Tuesday, June 19^that the 2012 BIO International Convention in Boston, MA.

Moderated by BIO’s President & CEO Jim Greenwood, the panel will discuss global economic challenges and the need to balance austerity and growth, and how these challenges and public policy reactions will affect biotechnology innovation and investment in the years ahead.

“Convention attendees have come to expect Keynote’s that feature timely and relevant industry experts and topics. This year will prove no exception as we hear from former economic leaders who will delve into the issues facing the global economy and what this means for the future of the industry,” said BIO President & CEO Jim Greenwood. “We are honored to have such knowledgeable decision-makers share their insights and experience with us.”

Immediately preceding the moderated panel discussion, Greenwood will deliver his annual State of the Industry Address to Convention attendees. Additionally, the Keynote will feature the presentation of awards for the International BioGENEius Challenge and the Biotechnology Heritage Award.

Tuesday’s Keynote session is sponsored by Janssen Pharmaceutical Companies of Johnson & Johnson, a global leader dedicated to addressing the world’s most important unmet medical needs.

The Tuesday Keynote Luncheon is open to Full Convention and Convention Access registrants, special guests and Industry Trade Press only.

The BIO International Convention will highlight the latest trends and the newest opportunities for executives, investors, scientists, policy leaders, and media from around the world. Speakers at the sessions will share breakthroughs in medicine, diagnostics, the environment, energy production, business operations, financing, partnerships, policy issues and food and agriculture. Visit http://convention.bio.org/program/ for the most up-to-date program and speaker information.

The Convention also features the BIO Business Forum, a unique platform for biotechnology and pharmaceutical companies, academic research institutions, and investors from around the world to gather and discuss strategic opportunities. For registration, conference agenda and exhibitor information, visit 2012 BIO International Convention.